An open-label phase I dose-finding study of APR-246 in hematological malignancies

Por Deneberg, S, Cherif, H, Lazarevic, V, Andersson, P-O, von Euler, M, Juliusson, G, Lehmann, S
Publicado no Blood Cancer J (2016)

In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy

Por Ruppé, E., Cherkaoui, A., Wagner, N., La Scala, G.C., Beaulieu, J.-Y., Girard, M., Frey, J., Lazarevic, V., Schrenzel, J.
Publicado no New Microbes New Infect (2017)

Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden

Por Juliusson, G, Abrahamsson, J, Lazarevic, V, Antunovic, P, Derolf, Å, Garelius, H, Lehmann, S, Myhr-Eriksson, K, Möllgård, L, Uggla, B, Wahlin, A, Wennström, L, Höglund, M
Publicado no Leukemia (2017)

Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience

Por Lazarevic, V, Hörstedt, A-S, Johansson, B, Antunovic, P, Billström, R, Derolf, Å, Hulegårdh, E, Lehmann, S, Möllgård, L, Nilsson, C, Peterson, S, Stockelberg, D, Uggla, B, Wennström, L, Wahlin, A, Höglund, M, Juliusson, G
Publicado em 2014